Latest "Altus Capital Partners" News Stories

20:01 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Altus Capital Partners" found in our extensive news archives from over 250 global news sources.

More Information about Altus Capital Partners on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Altus Capital Partners for you to read. Along with our medical data and news we also list Altus Capital Partners Clinical Trials, which are updated daily. BioPortfolio also has a large database of Altus Capital Partners Companies for you to search.

Showing "Altus Capital Partners" News Articles 1–25 of 7,000+

Extremely Relevant

Altus Capital Partners buys ChoiceSpine

Altus Capital Partners has paid an undisclosed amount for spinal fusion hardware and biologics company ChoiceSpine.  -More- 

ChoiceSpine scooped up by Altus Capital

Altus Capital Partners is buying closely held spinal device maker ChoiceSpine, LP for an undisclosed sum.

Altus Capital completes second acquisition in medical technology industry

Based in Knoxville, Tennessee, ChoiceSpine designs, manufactures and markets spinal implants, instrumentation and biologies for surgical treatment of complex spine disorders. It was founded in 2006. The company offers The post Altus Capital completes second acquisition in medical technology industry appeared first on Compelo Medical Devices.

Altus Power Acquires Sponsor Member Interests in Solar Tax Equity Partnership

GREENWICH, Conn., Jan. 8, 2019 /PRNewswire/ -- Altus Power America, Inc. with its subsidiaries ("Altus Power") has successfully completed the acquisition of sponsor member shares Read more...


Altus Capital Partners, Inc. Acquires ChoiceSpine, LP

Completes third acquisition in less than two years and second in the medical technology industry Altus Capital Partners, Inc. (“Altus”), an investment firm focused on the North American manufacturing sector, today announced it has acquired

Abris Capital Partners vend Urgent Cargus, le nº 2 de la livraison express en Roumanie

VARSOVIE, Pologne, September 27, 2018 /PRNewswire/ -- Abris Capital Partners, gestionnaire de fonds de capital-investissement privé d'Europe centrale et de l'Est, a vendu 100 % Read more...

Medigene: Leerverkäufer GSA Capital Partners hat sich deutlich zurückgezogen

Martinsried ( - Leerverkäufer GSA Capital Partners LLP verringert Netto-Leerverkaufsposition in Medigene-Aktien signifikant: Die Leerverkäufer des Hedgefonds GSA Capital Partners...

Glilot Capital Partners Raises $110 Million for Its Third Fund

TEL AVIV, Israel, Oct. 15, 2018 /PRNewswire/ -- Glilot Capital Partners a Venture capital fund which invests in early-stage startups, has announced the closing of Read more...

M&As this week: Ampersand Capital Partners, Bioblast Pharma, Synteract

Ampersand Capital Partners has acquired and merged biomarker testing services provide Pacific Biomarkers into its existing portfolio company, NEOMED-LABS. The...Read More... The post M&As this week: Ampersand Capital Partners, Bioblast Pharma, Synteract appeared first on Drug Development Technology.

VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital Partners

August 17, 2018 ( Newswire) VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has tapped investment firm Merida Capital Partners (Merida) as its strategic partner.

Second Avenue Capital Partners Reaches Agreement To Provide Exit Financing For A'GACI

BOSTON, Aug. 20, 2018 /PRNewswire/ -- Second Avenue Capital Partners, LLC, announced it has provided a $12,000,000 revolving line of credit to A'GACI, LLC, a Read more...

Neurodegenerative disease start-up CuraSen raises $54.5mm Series A round

CuraSen Therapeutics Inc. (focused on small-molecule drugs to treat neurodegenerative diseases) brought in $54.5mm through it...

Summer Street Capital Partners Announces Sale of Apple Valley Waste

BUFFALO, N.Y., Dec. 3, 2018 /PRNewswire/ -- Summer Street Capital Partners, LLC (, a private equity fund based in Buffalo, NY, announced it has completed Read more...

Attune Pharma closes $23mm Series B

Attune Pharmaceuticals Inc. (oral small-molecule therapies) raised $23mm through a Series B financing led by Venrock Healthca...

Magnetar Capital Partners LP - Form 8.3 - BTG PLC


Pfizer partners with Bain Capital to launch new CNS therapy firm

Pfizer has partnered with private investment firm Bain Capital to launch a new company, Cerevel Therapeutics, for the development of...Read More... The post Pfizer partners with Bain Capital to launch new CNS therapy firm appeared first on Pharmaceutical Technology.

Abris Capital Partners plant Verkauf von Rumäniens zweitgrößtem Kurierdienst Urgent Cargus

WARSCHAU, Polen, September 27, 2018 /PRNewswire/ -- Der mittel-und osteuropäische Private-Equity Vermögensverwalter Abris Capital Partners hat 100 % seiner Anteile am rumänischen Portfoliounternehmen Urgent Cargus Read more...

Milestone Pharmaceuticals closes $80mm Series D round

Cardiovascular-focused Milestone Pharmaceuticals Inc. raised $80mm in what looks to be its Series D financing led by RTW Inve...

Series B lands $70mm for Akero

Just six months after its $65mm Series A financing, Akero Therapeutics Inc. has now raised $70mm through a Series B round led...

Maranon Capital Provides Financing to EyeSouth Partners, a Portfolio Company of Shore Capital Partners

Maranon Capital, L.P. today announced that it was Documentation Agent for a senior credit facility to support EyeSouth Partners’ (“EyeSouth”) strategic partnership with Florida Eye Microsurgical Institute and future growth. EyeSouth is a portfolio company of Shore Capital Partners, LLC. Headquartered in Atlanta, Georgia, EyeSouth is an eye c...

KaNDy Therapeutics raises £25mm in Series C round

UK-based KaNDy Therapeutics (female sex-hormone related conditions) completed a £25mm ($32.2mm) Series C round from new back...

Bright Health Raises $200M to Expand Care Partner Health Plan Model

Bright Health, a provider of exclusive Care Partner Health Plans for everyday individuals at competitive prices has raised $200M in Series C funding. Investors in the Series C round includes two new investors, Declaration Partners and Meritech Capital, as well as existing investors Bessemer Venture Partners, Cross Creek Advisors, Flare Capital, Greenspring Associates, Greycroft Partners, ... Read ...

NextCure closes $93mm Series B round

NextCure Inc. (immunotherapies) raised $93mm through its Series B round. Hillhouse Capital and Quan Capital led, and were joi...

Startup Verato secures $10M for patient matching technology

Bessemer Venture Partners and Columbia Capital led the round, and Blue Heron Capital and California Health Care Foundation also participated.

Magnetar Capital Partners LP - Form 8.3 - BTG PLC (Amendment)

Magnetar Capital Partners LP - Form 8.3 - BTG PLC (Amendment) PR Newswire London, December 10 FORM 8.3 AMENDMENT TO SECTION 2.(a) and 3.(b) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY...

Quick Search


News Quicklinks